Specificity of TGF-β1 Signal Designated by LRRC33 and Integrin Αvβ8.

Zelin Duan,Xuezhen Lin,Lixia Wang,Qiuxin Zhen,Yuefeng Jiang,Chuxin Chen,Jing Yang,Chia-Hsueh Lee,Yan Qin,Ying Li,Bo Zhao,Jianchuan Wang,Zhe Zhang

DOI: https://doi.org/10.1038/s41467-022-32655-9

IF: 16.6

2022-01-01

Nature Communications

Abstract:Myeloid lineage cells present the latent form of transforming growth factor-β1 (L-TGF-β1) to the membrane using an anchor protein LRRC33. Integrin αVβ8 activates extracellular L-TGF-β1 to trigger the downstream signaling functions. However, the mechanism designating the specificity of TGF-β1 presentation and activation remains incompletely understood. Here, we report cryo-EM structures of human L-TGF-β1/LRRC33 and integrin αVβ8/L-TGF-β1 complexes. Combined with biochemical and cell-based analyses, we demonstrate that LRRC33 only presents L-TGF-β1 but not the -β2 or -β3 isoforms due to difference of key residues on the growth factor domains. Moreover, we reveal a 2:2 binding mode of integrin αVβ8 and L-TGF-β1, which shows higher avidity and more efficient L-TGF-β1 activation than previously reported 1:2 binding mode. We also uncover that the disulfide-linked loop of the integrin subunit β8 determines its exquisite affinity to L-TGF-β1. Together, our findings provide important insights into the specificity of TGF-β1 signaling achieved by LRRC33 and integrin αVβ8.